Diabetes

Individuals who are insulin-resistant are 2.66 times more likely to suffer from major depression than those who are not insulin-resistant.

Taking all 3 doses also helped patients experience higher A1C levels than patients who took titrated insulin glargine, clinical trial results show.

Temelimab is a recombinant humanized IgG4 monoclonal antibody that blocks the HERV-W protein, which is associated with the pathology of autoimmune disorders, such as multiple sclerosis and type 1 diabetes.

Semaglutide acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP-1 receptor.

Medication adherence, diet, and exercise are each critical components in caring for patients with a chronic illness, but each is difficult to be managed by physicians alone.

The national guidelines recommend a heart-healthy diet to help manage weight and control blood pressure, while also emphasizing dietary patterns rather than individual foods and nutrients.

Semaglutide (Rybelsus) is a glucagon-like peptide-1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

This month's case studies include questions about continuous glucose monitoring, diabetes neuropathic pain, diabetes and colds, and smoking cessation.

T2D is associated with a higher mortality risk linked to the coronavirus than individuals with T1D.

Study shows that shedding pounds potentially decreases the risk of diabetes, dyslipidemia, and high blood pressure.

Dasiglucagon increases blood glucose concentration by activating hepatic glucagon receptors, thereby stimulating glycogen breakdown and release of glucose from the liver.

Guidance on the use of basal insulins (BI) and insulin pens to enable pharmacists to answer questions regarding the safe and effective use of BI for the management of diabetes.

There are many substances that are included on the prohibited list for the Tokyo Olympics that are considered standard medications for certain disease states.

The research team analyzed the associations between maternal diabetes before or during pregnancy and the risk of high refractive error (RE), which are conditions in which there is a failure of the eye to properly focus images on the retina.

The results of a new study show that when coronavirus-infected diabetic mice were injected with an interferon beta, SETDB2 increased and helped decrease the inflammatory cytokines.

Diabetic kidney disease develops in nearly 40% of patients with diabetes and serves as the leading cause of chronic kidney disease worldwide, according to the study.

Peptides that cause migraine pain can influence insulin production in mice, possibly by regulating the amount of secreted insulin or by increasing the number of pancreatic cells that produce it.

In addition to early screening, counseling patients on preventive interventions can reduce the risk of developing prediabetes or type 2 diabetes.

According to the investigators, both trials demonstrated an overall well-tolerated safety profile for brolucizumab.

Semaglutide is a once weekly subcutaneous injection that was granted FDA approval for use in adults with obesity or overweight with at least one other weight related-condition.

The expanded indication follows Lyumjev’s original approval in 2020 and offers an important new delivery mechanism for patients with diabetes.

HDHPs require patients to pay for all care out of pocket until the plan’s deductible is reached, and only after this threshold does insurance start to cover medical costs.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Pharmacists are in a strong position to identify the early warning signs of diabetes because they are often the most accessible and frequently visited members of the health care team.

The introduction of a biosimilar insulin could result in major shifts in the accessibility and affordability of insulin for all patients.

Depending on the patient needs, the prescriber can prescribe one or both types of insulin.

Antidepressants may lower the risk of death and serious complications from diabetes for patients with both diabetes and depression, according to a study published in the Journal of Clinical Endocrinology & Metabolism.